Corrosion of Metallic Implants

Joint Replacement and Bone Resorption: Pathology, Biomaterials, and Clinical Practice

Volumn , Issue , 2005, Pages 211-253

  Hallab, Nadim James ^a   Jacobs, Joshua J ^a   Gilbert, Jeremy L ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64849099913     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14138-14     Document Type: Chapter

References (128)

1. Black J. Orthopaedic Biomaterials in Research and Practice. New York: Churchill Livingstone, 1988.
2. Jacobs JJ, Gilbert JL, Urban RM. Corrosion of metal orthopaedic implants. J Bone Joint Surg Am 1998; 80: 268-282.
3. Lacombe P. Corrosion and oxidation of Ti and Ti alloys. In: Ti, Ti Alloys, Williams JC, Belor AF, eds. New York: Plenum Press, 1982: 847-880.
4. Aladjem A. Review: Anodic oxidation of titanium and its alloys. J Mater Sci 1973; 8: 688-704.
5. Cabrera N, Mott NF. Physics 1948; 12: 163-164
6. Fraker A, Ruff AW, Yeager M. Studies of oxide film formation on titanium alloys in physiological solutions. Corros Sci 1973; 11: 763-765.
7. Brown GM, Thundat T, Allison DA, Warmack RJ. Electrochemical and in-situ atomic force microscopy investigation of tiatnium in oxalic acid. J Vac Sci Technol 1992; 10: 3001-3006.
8. Healy KE, Ducheyne P. The mechanisms of passive dissolution of titanium in model physiologic environment. J Biomed Mater Res 1992; 26: 181-186.
9. Williams RL, Brown SA, Merritt K. Electrochemical studies on the influence of proteins on the corrosion of implant alloys. Biomaterials 1988; 9: 181-186.
10. Wishey A, Gregson PJ, Peter LM. Effect of surface treatment on the dissolution of titanium based implant materials. Biomaterials 1991; 12: 470-473.
11. MacDonald JR. Impedance Spectroscopy New York: Wiley Interscience, 1987.
12. Gilbert JL, Smith SM, Lautenschlager EP. Scanning electrochemical microscopy of metallic biomaterials: reaction rate and ion release imaging modes. J Biomed Mater Res 1993; 27: 1357-1366.
13. Bard AJ, Faulkner LR. Electrochemical Methods. New York: Wiley, 1980.
14. Pourbaix M. Electrochemical corrosion of metallic biomaterials. Biomaterials 1984; 5: 122-134.
15. Lewis G, Daigle K. Electrochemical behavior of T-6A1-4V alloy in static biosimulationg solutions. J Biomed Mater Res Appl Biomater 1993; 4: 47-54.
16. Gilbert JL, Buckley CA, Jacobs JJ, Bertin KC, Zernich MR. Intergranular corrosion-fatigue failure of cobalt-alloy femoral stems. A failure analysis of two implants. J Bone Joint Surg Am 1994; 76: 110-115.
17. Collier JP, Suprenant VA, Jensen RE, Mayor MB, Suprenant HP. Corrosion between the components of modular femoral hip prosthesis. J Bone Joint Surg 1992; 74B: 511-517.
18. Gilbert JL, Buckley CA, Jacobs JJ. In vivo corrosion of modular hip prosthesis components in mixed and similar metal combinations. The effect of crevice, stress, motion, and alloy coupling. J Biomed Mater Res 1993; 27: 1533-1544.
19. Gilbert JL, Jacobs J. The mechanical and electrochemical processes associated with taper frettg crevice corrosion: a review. In: ASTM STP 1301 Modularity of Orthopaedic Implants. Philidelphia: ASTM, 1997: 45-59.
20. Bundy K. Bone prosthesis and implant materials. In: Cowin SC, ed. Bone Mechanics. Boca Raton: CRC Press, 1989: 160-184.
21. Park JB. Biomaterials Science and Engineering. New York: Plenum Press, 1984.
22. Silver FH, Christiansen DL. Biomaterials Science and Biocompatibility. New York: Springer, 1999.
23. Breme J, Biehl V. Metallic biomaterials. In: Black J, Hastings G, eds. Handbook of Biomaterial Properties. London: Chapman and Hall, 2001.
24. Black J. Biomaterials. New York: Marcel Dekker, 1992.
25. Black J. Prosthetic Materials. New York: VCH Publishers, 1996.
26. Hallab NJ, Jacobs JJ, Skipor A, Black J, Mikecz K, Galante JO. Systemic metal-protein binding associated with total joint replacement arthroplasty. J Biomed Mater Res 2000; 49: 353-361.
27. Hallab NJ, Mikecz K, Akrami J, Jacobs J. Differential metal release and protein binding associated with titanium and cobalt-chromium implant alloys. Trans 46th Orthop Res Soc Orlando, Fl, 2000.
28. Michel R, Nolte M, Reich M, Loer F. Systemic effects of implanted prostheses made of cobalt-chromium alloys. Arch Orthop Trauma Surg 1991; 110: 61-74.
29. Jacobs JJ, Silverton C, Hallab NJ, Skipor AK, Patterson L, Black J, Galante JO. Metal release and excretion from cementless titanium alloy total knee replacements. Clin Orthop 1999; 358: 173-180.
30. Jacobs JJ, Skipor AK, Patterson LM, Hallab NJ, Paprosky WG, Black J, Galante JO. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am 1998; 80: 1447-1458.
31. Urban RM, Jacobs J, Gilbert JL, Rice SB, Jasty M, Bragdon CR, Galante GO. Characterization of solid products of corrosion generated by modular-head femoral stems of different designs and materials. In: Marlowe DE, Parr JE, Mayor MB, eds. STP 1301 Modularity of Orthopaedic Implants. Philadelphia: ASTM, 1997: 33-44.
32. Urban RM, Jacobs JJ, Tomlinson MJ, Gavrilovic J, Black J, Peoc’h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am 2000; 82: 457-476.
33. Urban RM, Jacobs JJ, Gilbert JL, Galante JO. Migration of corrosion products from modular hip prostheses. Particle microanalysis and histopathological findings. J Bone Joint Surg Am 1994; 76: 1345-1359.
34. Jasty M, Goetz DD, Bragdon CR, Lee KR, Hanson AE, Elder JR, Harris WH. Wear of polyethylene acetabular components in total hip arthroplasty. An analysis of one hundred and twenty-eight components retrieved at autopsy or revision operations. J Bone Joint Surg Am 1997; 79: 349-358.
35. Jacobs JJ, Urban RM, Gilbert JL, Skipor AK, Black J, Jasty M, Galante JO. Local and distant products from modularity. Clin Orthop 1995; 319: 94-105.
36. Jacobs JJ, Skipor AK, Urban RM, Black J, Manion LM, Starr A, Talbert LF, Galante JO. Systemic distribution of metal degradation products from titanium alloy total hip replacements an autopsy study. Trans Orthop Res Soc 1994: 838.
37. Stulberg BN, Merritt K, Bauer T. Metallic wear debris in metal-backed patellar failure. J Biomed Mater Res Appl Biomater 1994; 5: 9-16.
38. Jacobs JJ, Shanbhag A, Glant JJ, Black J, Galante JO. Wear debris in total joints. J Am Acad Orthop Surg 1994; 2: 212-220.
39. Jacabs JJ. NIH Consensus Conference. Total hip replacement. JAMA 1995; 273: 1950-1956.
40. Glant TT, Jacobs JJ, Molnar G, Shanbagh AS, Valyon M, Galante JO. Bone resorption activity of particulate-stimulated macrophages. J Bone and Mineral Res 1993; 8: 1071-1079.
41. Woodman JL, Jacobs JJ, Galante JO, Urban RM. Metal ion release from titanium-based prosthetic segmental replacements of long bones in baboons: a long-term study. J Orthop Res 1984; 1: 421-430.
42. Gitelman H. Aluminum and Health, a Critical Review. New York: Dekker, 1989.
43. Williams DF. Biological effects of titanium. In: Williams DF, ed. Systemic Aspects of Biocompatibility. Boca Ratan: CRC Press, 1981: 169-177.
44. Gillespie WJ, Frampton CM, Henderson RJ, Ryan PM. The incidence of cancer following total hip replacement. J Bone Joint Surg Br 1988; 70: 539-542.
45. Bravo I, Carvalho GS, Barbosa MA, de Sousa M. Differential effects of eight metal ions on lymphocyte differentiation antigens in vitro. J Biomed Mater Res 1990; 24: 1059-1068.
46. Sinibaldi K, Rosen H, Liu SK, DeAngelis M. Tumors associated with metallic implants in animals. Clin Orthop 1976: 257-266.
47. Luckey TD, Venugopal B. Metal Toxicity in Mammals.NewYork: Plenum, 1979.
48. Sederholm T, Kouvalainen K, Lamberg BA. Cobalt-induced hypothyroidism and polycythemia in lipoid nephrosis. Acta Med Scand 1968; 184: 301-306.
49. Hartwig A. Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol Lett 1998; 102-103: 235-239.
50. Hayes RB. The carcinogenicity of metals in humans. Cancer Causes Control 1997; 8: 371-385.
51. Costa M. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit Rev Toxicol 1997; 27: 431-442.
52. Beyersmann D. Interactions in metal carcinogenicity. Toxicol Lett 1994; 72: 333-338.
53. Sunderman FW. Carcinogenicity of metal alloys in orthopaedic prosthesis: Clinical and experimental studies. Fundam Appl Toxicol 1989; 13: 205-216.
54. Jandhyala BS, Hom GJ. Minireview. Physiological and pharmacological properties of vanadium. Life Sci 1983; 33: 1325-1340.
55. Naylor GJ, Smith AH, Bryce-Smith D, Ward NI. Tissue vanadium levels in manic-depressive psychosis. Psychol Med 1984; 14: 767-772.
56. Garabrant DH, Fine LJ, Oliver C, Bernstein L, Peters JM. Abnormalities of pulmonary function and pleural disease among titanium metal production workers. Scand J Work Environ Health 1987; 13: 47-51.
57. 2 dust deposition. Environ Res 1986; 41: 144-167.
58. Altmann P, Plowman D, Marsh F, Cunningham J. Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium. Lancet 1988; 1: 1012-1015.
59. Coburn JW, Norris KC, Nebeker HG. Osteomalacia and bone disease arising from aluminum. Semin Nephrol 1986; 6: 68-89.
60. Good PF, Perl DP. Aluminium in Alzheimer’s. Nature 1993; 362: 418.
61. Memoli VA, Urban RM, Alroy J, Galante JO. Malignant neoplasms associated with orthopaedic implant materials in rats. J Orthop Res 1986; 4: 346-355.
62. Jacobs JJ, Rosenbaum DH, Hay RM, Gitelis S, Black J. Early sarcomatous degeneration near a cementless hip replacement. A case report and review. J Bone Joint Surg Br 1992; 74: 740-744.
63. Goodfellow J. Malignancy and joint replacement. J Bone Joint Surg Br 1992; 74: 645.
64. Visuri T, Koskenvuo M. Cancer risk after Mckee-Farrar total hip replacement. Orthopaedics 1991; 14: 137-142.
65. Sunderman FW, Hopfer SM, Swift T, Rezuke WN, Ziebka L, Highman P, Edwards B, Folcik M, Gossling HR. Cobalt, chromium, and nickel concentrations in body fluids of patients with porous-coated knee or hip prostheses. J Orthop Res 1989; 7: 307-315.
66. Blumenthal NC, Cosma V. Inhibition of apatite formation by titanium and vanadium ions. J Biomed Mater Res 1989; 23: 13-22.
67. Blumenthal NC, Cosma V. The effect of aluminum and gallium ions on the mineralization process. Bull Hosp Joint Dis Orthop Inst 1989; 49: 192-204.
68. Sun ZL, Wataha JC, Hanks CT. Effects of metal ions on osteoblast-like cell metabolism and differentiation. J Biomed Mater Res 1997; 34: 29-37.
69. Wataha JC, Hanks CT, Sun Z. Effect of cell line on in vitro metal ion cytotoxicity. Dent Mater 1994; 10: 156-161.
70. Wataha JC, Hanks CT, Craig RG. In vitro effects of metal ions on cellular metabolism and the correlation between these effects and the uptake of the ions. J Biomed Mater Res 1994; 28: 427-433.
71. Wataha JC, Hanks CT, Craig RG. The effect of cell monolayer density on the cytotoxicity of metal ions which are released from dental alloys. Dent Mater 1993; 9: 172-176.
72. Nichols KG, Puleo DA. Effect of metal ions on the formation and function of osteoclastic cells in vitro. J Biomed Mater Res 1997; 35: 265-271.
73. Thompson GJ, Puleo DA. Ti-6Al-4V ion solution inhibition of osteogenic cell phenotype as a function of differentiation timecourse in vitro. Biomaterials 1996; 17: 1949-1954.
74. Thompson GJ, Puleo DA. Effects of sublethal metal ion concentrations on osteogenic cells derived from bone marrow stromal cells. J Appl Biomater 1995; 6: 249-258.
75. Puleo DA, Huh WW. Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells. J Appl Biomater 1995; 6: 109-116.
76. Morais S, Dias N, Sousa JP, Fernandes MH, Carvalho GS. In vitro osteoblastic differentiation of human bone marrow cells in the presence of metal ions. J Biomed Mater Res 1999; 44: 176-190.
77. Morais S, Sousa JP, Fernandes MH, Carvalho GS, de Bruijn JD, van Blitterswijk CA. Effects of AISI 316L corrosion products in invitro bone formation. Biomaterials 1998; 19: 999-1007.
78. Morais S, Sousa JP, Fernandes MH, Carvalho GS. In vitro biomineralization by osteoblast-like cells. I. Retardation of tissue mineralization by metal salts. Biomaterials 1998; 19: 13-21.
79. Wagner M, Klein CL, van Kooten TG, Kirkpatrick CJ. Mechanisms of cell activation by heavy metal ions. J Biomed Mater Res 1998; 42: 443-452.
80. Roebuck KA, Vermes C, Carpenter LR, Fritz EA, Narayanan R, Glant TT. Down-regulation of procollagen alpha1(I) messenger RNA by titanium particles correlates with nuclear factor kappaB (NF-kappaB) activation and increased rel A and NF-kappaB1 binding to the collagen promoter. J Bone Miner Res 2001; 16: 501-510.
81. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am 2001; 83: 201-211.
82. Vermes C, Roebuck KA, Chandrasekaran R, Dobai JG, Jacobs JJ, Glant TT. Particulate wear debris activates protein tyrosine kinases and nuclear factor kappaB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 2000; 15: 1756-1765.
83. Basketter DA, Briatico-Vangosa G, Kaestner W, Lally C, Bontinck WJ. Nickel, cobalt and chromium in consumer products: a role in allergic contact dermatitis? Contact Dermat 1993; 28: 15-25
84. Cramers M, Lucht U. Metal sensitivity in patients treated for tibial fractures with plates of stainless steel. Acta Orthop Scand 1977; 48: 245-249.
85. Merritt K, Rodrigo JJ. Immune response to synthetic materials, Sensitization of patients receiving orthopaedic implants. Clin Orthop Rel Res 1996; 326: 71-79.
86. Gawkrodger DJ. Nickel sensitivity and the implantation of orthopaedic prostheses. Contact Dermat 1993; 28: 257-259.
87. Kanerva L, Sipilainen-Malm T, Estlander T, Zitting A, Jolanki R, Tarvainen K. Nickel release from metals, and a case of allergic contact dermatitis from stainless steel. Contact Dermat 1994; 31: 299-303.
88. Haudrechy P, Foussereau J, Mantout B, Baroux B. Nickel release from nickelplated metals and stainless steels. Contact Dermat 1994; 31: 249-255.
89. Black J. Systemic effects of biomaterials. Biomaterials 1984; 5: 12-17.
90. Jacobs JJ, Gilbert JL, Urban RM.Corrosion of metallic implants. In: Stauffer RN, ed. Advances in Orthopaedic Surgery. Vol. 2. St. Louis: Mosby, 1994: 279-319.
91. Yang J, Black J. Competitive binding of chromium cobalt and nickel to serum proteins. Biomaterials 1994; 15: 262-268.
92. Yang J, Merritt K. Production of monoclonal antibodies to study corrosion of Co-Cr biomaterials. J Biomed Mater Res 1996; 31: 71-80.
93. Liden C, Wahlberg JE, Maibach HI. Skin. New York: Academic Press, 1995: 447-464.
94. Angle C. Organ-Specific Therapeutic Intervention. New York: Academic Press, 1995: 71-110.
95. Lalor PA, Revell PA, Gray AB, Wright S, Railton GT, Freeman MA. Sensitivity to titanium. A cause of implant failure. J Bone Joint Surg 1991; 73-B: 25-28.
96. Parker AW, Drez D Jr, Jacobs JJ. Titanium dermatitis after failure of a metalbacked patellas. Am J Knee Surg 1993; 6: 129-131.
97. Hensten-Pettersen A. Allergy and hypersensitivity. In: Morrey BF, ed. Biological, Material and Mechanical Considerations of Joint Replacements. New York: Raven Press, 1993: 353-360.
98. Kuby J. Immunology. New York: W.H. Freeman and Company, 1991.
99. Merle C, Vigan M, Devred D, Girardin P, Adessi B, Laurent R. Generalized eczema from vitallium osteosynthesis material. Contact Dermat 1992; 27: 257-258.
100. King J, Fransway A, Adkins RB. Chronic urticaria due to surgical clips. N Engl J Med 1993; 329: 1583-1584.
101. Barranco VP, Solloman H. Eczematous dermatitis from nickel. J Am Med Assoc 1972; 220: 1244.
102. Thomas RH, Rademaker M, Goddard NJ, Munro DD. Severe eczema of the hands due to an orthopaedic plate made of vitallium. Br Med J 1987; 294: 106-107.
103. Abdallah HI, Balsara RK, O’Riordan AC. Pacemaker contact sensitivity: Clinical recognition and management. Ann Thora Surg 1994; 57: 1017-1018.
104. Halpin DS. An unusual reaction in muscle in association with a vitallium plate: a report of possible metal hypersensitivity. J Bone Joint Surg 1975; 57-B: 451-453.
105. Merritt K, Brown SA. Biological Effects of Corrosion Products from Metal. Philadelphia: American Society for Testing and Materials, 1985: 195-207.
106. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthoplasty. Clin Orthop 1984: 182.
107. Wang JY, Wicklund BH, Gustilo RB, Tsukayama DT. Prosthetic metals interfere with the functions of human osteoblast cells in vitro. Clin Orthop 1997: 216-226.
108. Elves MW, Wilson JN, Scales JT, Kemp HB. Incidence of metal sensitivity in patients with total joint replacements. Br Med J 1975; 4: 376-378.
109. Gordon PM, White MI, Scotland TR. Generalized sensitivity from an implanted orthopaedic antibiotic minichain containing nickel. Contact Dermat 1994; 30: 181-182.
110. Peters MS, Schroeter AL, Hale HM, Broadbent JC. Pacemaker contact sensitivity. Contact Dermat 1984; 11: 214-218.
111. Rostoker G, Robin J, Binet O, Blamutier J, Paupe J, Lessana-Liebowitch M, Bedouelle J, Sonneck JM, Garrel JB, Millet P. Dermatitis due to orthopaedic implants. A review of the literature and report of three cases. J Bone Joint Surg 1987; 69-A: 1408-1412.
112. Benson MK, Goodwin PG, Brostoff J. Metal sensitivity in patients with joint replacement arthroplasties. Br Med J 1975; 4: 374-375.
113. Brown GC, Lockshin MD, Salvati EA, Bullough PG. Sensitivity to metal as a possible cause of sterile loosening after cobalt-chromium total hip-replacement arthroplasty. J Bone Joint Surg Am 1977; 59-A: 164-168.
114. Deutman R, Mulder TH, Brian R, Nater JP. Metal sensitivity before and after total hip arthroplasty. J Bone Joint Surg Am 1977; 59-A: 862-865.
115. Kubba R, Taylor JS, Marks KE. Cutaneous complications of orthopaedic implants. A two-year prospective study. Arch Dermatol 1981; 117: 554-560.
116. Mayor MB, Merritt K, Brown SA. Metal allergy and the surgical patient. Am J Surg 1980; 139: 477-479.
117. Merritt K, Brown S. Tissue reaction and metal sensitivity. Acta Orthop Scand 1980; 51: 403-411.
118. Merritt K, Brown S. Metal sensitivity reactions to orthopaedic implants. Int J Dermatol 1981; 20: 89-94.
119. Merritt K. Role of medical materials, both in implant and surface applications, in immune response and in resistance to infection. Biomaterials 1984; 5: 53-57.
120. Pinkston JA, Finch SC. A method for the differentiation of T and B lymphocytes and monocytes migrating under agarose. Stain Technol 1979; 54: 233-239.
121. Rooker GD, Wilkinson JD. Metal sensitivity in patients undergoing hip replacement. A prospective study. J Bone Joint Surg 1980; 62-B: 502-505.
122. Carlsson AS, Macnusson B, Moller H. Metal sensitivity in patients with metal-toplastic total hip arthroplasties. Acta Orthop Scand 1980; 51: 57-62.
123. Fischer T, Rystedt I, Safwenberg J, Egle I. HLA -A, -B, -C and -DR antigens in individuals with sensitivity to cobalt. Acta Derm Venereol Stockh 1984; 64: 121-124.
124. Munro-Ashman D, Miller AJ. Rejection of metal to metal prosthesis and skin sensitivity to cobalt. Contact Dermat 1976; 2: 65.
125. Evans EM, Freeman MA, Miller AJ, Vernon-Roberts B. Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Joint Surg 1974; 56-B: 626-642.
126. Boyan BD. Discussion of Toxicity and Allergy. New York: Raven Press, 1993.
127. Jacobs JJ, Skipor AK, Patterson LM, Black J, Galante JO. Serum titanium concentration in patients with cementless TKR: a 5-year prospective study. Trans ORS 1997; 22: 235.
128. Jacobs JJ, Skipor AK, Patterson LM, Paprosky WG, Black J, Galante JO. A prospective, controlled, longitidunal study of metal release in patients undergoing primary total hip arthroplasty. J Bone Joint Surg 2001.